Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:348-355
Published online before print January 2, 2009, doi: 10.1161/ATVBAHA.108.176685
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/3/348    most recent
ATVBAHA.108.176685v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, B. J.
Right arrow Articles by Lusis, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, B. J.
Right arrow Articles by Lusis, A. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:348.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Genetic Regulation of Atherosclerotic Plaque Size and Morphology in the Innominate Artery of Hyperlipidemic Mice

Brian J. Bennett; Susanna S. Wang; Xuping Wang; Xiaohui Wu; Aldons J. Lusis

From the Departments of Medicine (B.J.B., S.S.W., X.P.W., X.W., A.J.L.), Microbiology, Immunology, and Molecular Genetics (A.J.L.), and Human Genetics (A.J.L.), UCLA School of Medicine, University of California, Los Angeles.

Correspondence to Brian J. Bennett, Department of Medicine, 675 Charles E. Young Dr South, 3730 MRL, University of California at Los Angeles, Los Angeles, CA 90095-1679. E-mail bbennett{at}mednet.ucla.edu

Objective— We sought to determine the genetic factors contributing to atherosclerotic plaque size and cellular composition in the innominate artery, a murine model of advanced atherosclerosis.

Methods and Results— We examined genetic contributions to innominate atherosclerotic plaque size and cellular composition in an intercross between C57BL/6J.Apoe–/–, a strain susceptible to aortic lesions, and C3H/HeJ.Apoe–/–, a strain resistant to aortic lesions. Surprisingly, total innominate lesion size was similar in the two strains. Genetic analyses identified one novel locus on Chromosome 2 for innominate artery lesion size, a significant locus for fibrous cap thickness on Chromosome 15, and several suggestive loci for cellular composition, all distinct from loci influencing aortic lesions. The Chromosome 2 locus contains a candidate, CD44. We show that CD44 is expressed in the innominate artery and differs strikingly in expression between the parental strains.

Conclusion— Multiple aspects of innominate lesion composition are genetically determined, but in a manner largely independent of the genetic contributions to aortic lesions.

We sought to determine the genetic factors contributing to atherosclerotic plaque size and cellular composition in the innominate artery. We identified one novel locus on Chromosome 2 for innominate artery lesion size. Multiple aspects of innominate lesion composition are genetically determined, but in a manner independent of the aortic sinus.


Key Words: innominate artery • QTL • atherosclerosis • plaque stability